Accordingly, OMP-52M51 also reverses Notch-induced MYC, CCND1, and NPM1 gene expression as well as cell proliferation in NOTCH1-mutated CLL cells. This evidence concerns the gene NOTCH1 and B-cell chronic lymphocytic leukemia.